Nigeria Receives Breakthrough HIV Prevention Injection, Lenacapavir
Nigeria has officially received Lenacapavir, a long-acting injection used for Human Immunodeficiency Virus (HIV) prevention, marking a significant milestone in the country’s efforts to combat the epidemic. Approved by the Coordinating Minister of Health and Social Welfare, Professor Ali Pate, and supported by the Global Fund, the arrival of Lenacapavir reinforces Nigeria’s commitment to expanding innovative HIV prevention strategies. Designed for pre-exposure prophylaxis (PrEP), the injectable offers an alternative to daily oral medications, providing people at risk of HIV with a convenient, twice-yearly preventive option. Health experts say this could significantly improve adherence and access for populations who struggle with daily treatment schedules. The National Coordinator of the National HIV, Viral Hepatitis and STDs Control Programme (NASCP), Dr. Adebobola Bashorun, said the delivery of Lenacapavir underscores Nigeria’s dedication to using evidence-based innovations ...